KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Johnson & Johnson (JNJ) over the last 17 years, with Q4 2025 value amounting to $1.8 billion.

  • Johnson & Johnson's Capital Expenditures rose 1395.78% to $1.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.8 billion, marking a year-over-year increase of 922.24%. This contributed to the annual value of $4.8 billion for FY2025, which is 922.24% up from last year.
  • According to the latest figures from Q4 2025, Johnson & Johnson's Capital Expenditures is $1.8 billion, which was up 1395.78% from $1.2 billion recorded in Q3 2025.
  • Over the past 5 years, Johnson & Johnson's Capital Expenditures peaked at $1.8 billion during Q4 2025, and registered a low of $607.0 million during Q2 2022.
  • Its 5-year average for Capital Expenditures is $1.1 billion, with a median of $1.0 billion in 2024.
  • In the last 5 years, Johnson & Johnson's Capital Expenditures skyrocketed by 4217.46% in 2023 and then tumbled by 1316.73% in 2024.
  • Quarter analysis of 5 years shows Johnson & Johnson's Capital Expenditures stood at $747.0 million in 2021, then fell by 18.74% to $607.0 million in 2022, then surged by 161.78% to $1.6 billion in 2023, then rose by 1.45% to $1.6 billion in 2024, then rose by 13.96% to $1.8 billion in 2025.
  • Its Capital Expenditures stands at $1.8 billion for Q4 2025, versus $1.2 billion for Q3 2025 and $1.0 billion for Q2 2025.